US Patent 7718688 Nitrobenzindoles and their use in cancer therapy
Patent 7718688 was granted and assigned to Auckland Uniservices Limited on May, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+299 characters)
Article
Patent abstract
The present invention relates generally to nitro-1,2-dihydro-3H-benzo[e]indoles and related analogues, to their preparation, and to their use as hypoxia-selective drugs and radiosensitizers for cancer therapy, both alone or in combination with radiation and/or other anticancer drugs.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Adam Vorn Patterson0
Frederik Bastlaan Pruijn0
Graham John Atwell0
Moana Tercel0
Ralph James Stevenson0
Shangjin Yang0
William Alexander Denny0
William Robert Wilson0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07718688 Nitrobenzindoles and their use in cancer therapy US Patent 7718688 Nitrobenzindoles and their use in cancer therapy
Infobox
Patent Number
07718688
Patent Number
7718688
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07718688 Nitrobenzindoles and their use in cancer therapy
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07718688
Date of patent
May 18, 2010
Patent application number
11666014
Date Filed
October 21, 2005
Patent primary examiner
Find more entities like US Patent 7718688 Nitrobenzindoles and their use in cancer therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.